The purpose of this admendment  2 is to provide Questions and Answers (refer to attachment), dated 02 October 2024, and provide revisions made to Section C under Task 3 (items a and c) and Task 6 (item n) in attached RFP 75A50324R00004 Amendment 2.

The Center for the Strategic National Stockpile (SNS), of the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), has a requirement for Pegfilgrastim 6MG/.06ML (INJ, SOLN, SYR, or Autoinjector) and Vendor Managed Inventory (VMI) services (Refer to attached Request for Proposal (RFP) and Attachments (1-5).